SSRI Augmentation Could Increase Remission Rates As First-Line Therapy
Executive Summary
Augmentation of selective serotonin reuptake inhibitor initial therapy with another SSRI or other class of antidepressant agent could improve remission rates, authors of a study published in the March 23 New England Journal of Medicine suggested